Vaccine developer Moderna to be listed on Nasdaq-100 stock market index
Moderna shares jumped more than 15% in after-hours trading on Tuesday.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)
